1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Siemens Healthineers AG

Siemens Healthineers AG

SHL.DE
Siemens Healthineers AGDE flagDeutsche Börse
34.38
EUR
+0.13
- -
38.48BMarket Cap
Siemens Healthineers AG
SHL.DE
(Deutsche Börse)

Recent

price

34.38

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
12.94
13.55
13.68
13.43
14.53
14.43
16.37
19.34
19.37
20
- -
14.89
Revenue per Share
1.28
1.31
1.38
1.27
1.57
1.41
1.57
1.82
1.35
1.74
- -
1.34
Basic EPS, GAAP
1.54
1.42
1.04
1.07
1.04
1.37
2.05
1.47
1.14
1.9
- -
1.39
Free Cash Flow per Basic Share
0.15
0.38
0.35
1.01
0.7
0.8
0.78
0.85
0.95
0.95
- -
- -
Dividend per Share
4.38
3.24
4.04
-2.02
-0.86
-0.2
0.75
1.8
2.24
2.94
- -
3.71
Book Value per Share
-6.14
-7.38
-6.23
-1.07
-0.38
1.56
-8.53
-7.05
-6.89
-5.79
-21.1
-4.94
Tangible Book Value per Share
1,000
1,000
1,000
1,000
999
1,002
1,100
1,123
1,119
1,118
1,120
1,125
Basic Weighted Avg Shares
12,936
13,547
13,677
13,429
14,518
14,460
17,997
21,714
21,680
22,363
- -
16,744
Sales/Revenue/Turnover
15.17
15.63
16.25
14.6
15.81
13.44
14.27
13.47
9.84
12.56
- -
12.74
Operating Margin (%)
563
591
572
530
620
815
1,039
1,343
1,557
1,223
- -
927
Depreciation Expense
1,277
1,311
1,379
1,265
1,567
1,411
1,727
2,038
1,509
1,942
- -
1,507
Net Income, GAAP
31.13
30.76
29.39
28.63
27.68
27.23
27.37
26.64
20.9
22.35
- -
23.15
Effective Tax Rate (%)
9.87
9.68
10.08
9.42
10.79
9.76
9.6
9.39
6.96
8.68
- -
9
Profit Margin (%)
-6,092
-1,456
-2,316
1,896
2,174
2,979
759
1,355
696
2,870
- -
1,294
Working Capital
14
14
15
17
61
314
457
461
436
513
- -
503
LT Debt
3,728
2,505
3,289
8,676
9,782
12,511
16,339
19,852
18,133
18,248
- -
18,262
Total Equity
- -
44.67
49.36
21.79
16.92
11.78
11.9
10.92
8.21
11.06
- -
8.32
Return on Invested Capital (%)
- -
37.12
41.6
126.69
-124.56
-705.97
194.32
98.95
58.29
62.82
- -
37.58
Return on Capital (%)
- -
34.39
37.86
- -
- -
- -
- -
143.02
66.61
67.07
- -
40.52
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'26
Mar'26
ST Debt
269
272
318
LT Borrowings
- -
- -
- -
LT Finance Leases
487
- -
503
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,117
1,117
1,119
Market Capitalization
51,890
50,513
40,820

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'26
Mar'26
Total Current Assets
- -
14,194
14,179
Cash, Cash Equivalents & STI
73
2,608
2,298
Accounts Receivable, Net
4,603
4,478
4,585
Inventories
4,086
4,416
4,463
Total Current Liabilities
- -
13,652
12,885
Payables & Accruals
- -
- -
- -
ST Debt
269
272
318
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,176
5,435
5,423
6,329
22,363
2025
5,482
5,909
5,662
- -
- -
2026
5,402
5,680
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.39
- -
0.42
0.55
1.74
2025
0.42
- -
0.49
- -
- -
2026
0.4
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.95
- -
0.95
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
FUJIFILM Holdings Corporation (4901.T)
Visiomed Group (VMGBS.PA)
ALR Technologies Inc. (ALRTF)
ChemoMetec A/S (CHEMM.CO)
Siemens Healthineers AG (SEMHF)
Abiomed, Inc. (ABMD)
Business
Siemens Healthineers AG (SHL.DE) develops, manufactures and markets diagnostic and therapeutic products and services for healthcare providers worldwide; core offerings span Imaging with magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound devices; Diagnostics encompassing in-vitro testing including clinical chemistry analyzers, immunoassay systems, hematology, coagulation, urinalysis, blood gas analysis and molecular diagnostics; Varian segment providing multi-modality cancer care technologies, radiation oncology solutions and integrated digital workflows; Advanced Therapies featuring angiography systems, mobile C-arms and image-guided therapies; plus digital health services such as artificial intelligence in radiology, health data analytics, telemedicine platforms and workflow optimization tools. The company operates globally across Americas, Europe, Asia-Pacific, Middle East and CIS regions through approximately 72,000 employees, generating around €22 billion in revenue in fiscal year 2024 with key segments including Imaging at €11.8 billion, Diagnostics at €4.4 billion, Varian at €3.8 billion and Advanced Therapies at €2 billion. Headquartered in Forchheim near Erlangen, Germany with registered office in Munich, Siemens Healthineers traces its roots to 1847 as part of Siemens AG, which retains a 75% stake following the 2017 spin-off and 2018 IPO; it serves hospitals, clinics, laboratories and oncology centers with solutions influencing nearly three-quarters of critical clinical decisions. Recent developments include the December 2024 completion of its €200 million-plus acquisition of Novartis' Advanced Accelerator Applications Molecular Imaging business, adding 13 European radiopharmacies in France, Spain, Portugal, Italy and Germany plus a workforce of 420 to bolster PETNET Solutions' network for diagnostic radiopharmaceuticals in oncology, neurology and cardiology; a May 2025 announcement of $150 million U.S. investments in production expansion and job creation; and ongoing emphasis on AI integration and theranostics to drive precision medicine and growth in the €500 million PET sector projected to triple by 2033.